| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients (NCT06432166) | MTI Biotech Inc | 2025-09-01 |
| Combination Immunotherapy Targeting Melanoma (NCT06739226) | Shenzhen Geno-Immune Medical Institute | 2025-08-31 |
| A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma (NCT07090954) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2025-08-31 |
| HS-IT101 Injection for Advanced NSCLC (NCT07105176) | Qingdao Sino-Cell Biomedicine Co., Ltd. | 2025-08-30 |
| Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age (NCT06434038) | HealthPartners Institute | 2025-08-30 |
| Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls (NCT07018492) | Shionogi | 2025-08-30 |
| A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers (NCT07143331) | Klotho Sciences Australia Pty Ltd. | 2025-08-30 |
| A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers (NCT07146945) | Delphian Therapeutics Australia Pty, Ltd | 2025-08-30 |
| Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study (NCT07112586) | Ain Shams University | 2025-08-30 |
| A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45 (NCT07038824) | Entrada Therapeutics, Inc. | 2025-08-30 |
| Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD) (NCT06850870) | Onward Health, Inc | 2025-08-29 |
| An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial (NCT06999798) | Mayo Clinic | 2025-08-29 |
| A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution (NCT07139431) | Nuwacell Biotechnologies Co., Ltd. | 2025-08-29 |
| External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease (NCT06572605) | City of Hope Medical Center | 2025-08-29 |
| A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old (NCT07133828) | Biogen | 2025-08-29 |
| A Study of LM-350 in Subjects With Advanced Solid Tumours (NCT07112222) | LaNova Medicines Limited | 2025-08-28 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years (NCT07156201) | Actio Biosciences, Inc. | 2025-08-28 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. (NCT07377175) | China National Biotec Group Company Limited | 2025-08-28 |
| Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors (NCT07128303) | Gilead Sciences | 2025-08-28 |
| A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT07283796) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-28 |
| A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors (NCT07123129) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-08-28 |
| A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants (NCT07127770) | Pfizer | 2025-08-28 |
| Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) (NCT07110090) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-08-28 |
| GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults (NCT07087002) | Stanford University | 2025-08-28 |
| Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy (NCT07177196) | n-Lorem Foundation | 2025-08-28 |
| A Study of LY4064912 in Healthy Participants and With Overweight or Obesity (NCT07152002) | Eli Lilly and Company | 2025-08-28 |
| Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment (NCT06805994) | Johns Hopkins University | 2025-08-27 |
| Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) (NCT07047885) | H. Lee Moffitt Cancer Center and Research Institute | 2025-08-27 |
| A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755 (NCT07141381) | Voronoi, Inc | 2025-08-27 |
| A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors (NCT07147348) | BioNTech SE | 2025-08-27 |
| Q702 for the Treatment of Patients With Hematologic Malignancies (NCT06712810) | Mayo Clinic | 2025-08-27 |
| 3D1015 Injection for Patients With mCRPC (NCT07537010) | Chunjing Yu | 2025-08-27 |
| Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults (NCT07111078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-08-27 |
| Study of DCC-2812 in Participants With Advanced Genitourinary Cancers (NCT06966024) | Deciphera Pharmaceuticals, LLC | 2025-08-27 |
| Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma (NCT07093710) | Sun Yat-sen University | 2025-08-27 |
| Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults (NCT07161180) | Pharmbio Korea Co., Ltd. | 2025-08-27 |
| Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors (NCT07030257) | Tasca Therapeutics | 2025-08-27 |
| A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144 (NCT07636018) | Pfizer | 2025-08-26 |
| Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers (NCT07110441) | Genfit | 2025-08-26 |
| A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults (NCT07142850) | Jiangsu HengRui Medicine Co., Ltd. | 2025-08-26 |
| A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood (NCT07081932) | Boehringer Ingelheim | 2025-08-26 |
| To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery (NCT07121023) | Beijing Tide Pharmaceutical Co., Ltd | 2025-08-26 |
| A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors (NCT07169734) | Alentis Therapeutics AG | 2025-08-26 |
| Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT07156253) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2025-08-26 |
| Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma (NCT07754890) | Peking Union Medical College Hospital | 2025-08-26 |
| Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants (NCT07042594) | Suzhou Ribo Life Science Co. Ltd. | 2025-08-26 |
| A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants (NCT07142642) | Amgen | 2025-08-26 |
| A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors (NCT06973863) | PharmaEngine | 2025-08-26 |
| A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA) (NCT06977724) | AbbVie | 2025-08-26 |
| A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease (NCT07063823) | Nielsen Fernandez-Becker | 2025-08-26 |
| IDOV-Immune for Advanced Solid Tumors (NCT06910657) | ViroMissile, Inc. | 2025-08-25 |
| Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer (NCT06388369) | University Hospital, Essen | 2025-08-25 |
| Effects of Cannabidiol on Stress and Nicotine Withdrawal (NCT07001930) | Johns Hopkins University | 2025-08-25 |
| Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT06859008) | City of Hope Medical Center | 2025-08-25 |
| Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges (NCT07038746) | Dr. George Luciuk | 2025-08-25 |
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease (NCT06995573) | NSC-Therapeutics | 2025-08-25 |
| Gene Therapy for SLC6A1 Neurodevelopmental Disorder (NCT07173153) | Emily de los Reyes | 2025-08-25 |
| A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity (NCT06830863) | Azitra Inc. | 2025-08-25 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors (NCT07181473) | Phrontline Biopharma | 2025-08-25 |
| Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate) (NCT07132541) | Minia University | 2025-08-25 |
| SLV-324 Treatment of Metastatic Solid Tumors (NCT07108114) | Solve Therapeutics | 2025-08-25 |
| To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors (NCT07594964) | Shenzhen Xinhe Biomedical | 2025-08-25 |
| A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation (NCT07058974) | Icahn School of Medicine at Mount Sinai | 2025-08-25 |
| Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus (NCT07010835) | Excyte Biopharma Ltd | 2025-08-25 |
| DRonabinol Treatment of OSA (NCT06477952) | VA Office of Research and Development | 2025-08-25 |
| A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants (NCT07146750) | Sanofi | 2025-08-25 |
| A Study of XW003 Injection in Chinese Adolescents With Obesity (NCT07143227) | Hangzhou Sciwind Biosciences Co., Ltd. | 2025-08-25 |
| Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls (NCT07012005) | Shionogi | 2025-08-25 |
| To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients (NCT07201467) | Suzhou Alphamab Co., Ltd. | 2025-08-22 |
| Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers (NCT07207291) | Joincare Pharmaceutical Group Industry Co., Ltd | 2025-08-22 |
| Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients (NCT07201883) | Makassed General Hospital | 2025-08-22 |
| Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease (NCT04774536) | Mark Walters, MD | 2025-08-22 |
| Evaluation of Miricorilant on Liver Fat in Patients With MASLD (NCT06947304) | Corcept Therapeutics | 2025-08-22 |
| A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors (NCT07020117) | Aktis Oncology, Inc. | 2025-08-22 |
| The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy (NCT06911372) | Anna Stanhewicz, PhD | 2025-08-22 |
| To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects (NCT07036458) | JW Pharmaceutical | 2025-08-22 |
| Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors (NCT07151040) | One-carbon Therapeutics AB | 2025-08-22 |
| Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition. (NCT07266779) | Humanis Saglık Anonim Sirketi | 2025-08-22 |
| Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma (NCT05618925) | ImmunityBio, Inc. | 2025-08-22 |
| NAL ER IPF Respiratory Function and Safety Study (NCT07036029) | Trevi Therapeutics | 2025-08-21 |
| Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat (NCT07171619) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-08-21 |
| A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib (NCT07144111) | Genentech, Inc. | 2025-08-21 |
| Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants (NCT07024797) | AbbVie | 2025-08-21 |
| Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals With Co-Occurring Internalizing Disorders (NCT06545071) | University of Minnesota | 2025-08-21 |
| Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose) (NCT07737106) | Sinovac Biotech Co., Ltd | 2025-08-21 |
| Study of BHV-1300 in Graves' Disease (NCT06980649) | Biohaven Therapeutics Ltd. | 2025-08-21 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions (NCT06987773) | APR Applied Pharma Research s.a. | 2025-08-20 |
| A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas (NCT07018752) | The Lymphoma Academic Research Organisation | 2025-08-20 |
| A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors (NCT07090499) | Pfizer | 2025-08-20 |
| A Study of EDG-15400 in Healthy Adults (NCT07177066) | Edgewise Therapeutics, Inc. | 2025-08-20 |
| ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors (NCT06998407) | Avenzo Therapeutics, Inc. | 2025-08-20 |
| A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023) (NCT07049939) | Merck Sharp & Dohme LLC | 2025-08-20 |
| A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 (NCT07230652) | Luye Pharma Group Ltd. | 2025-08-20 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma (NCT06960382) | University of Zurich | 2025-08-20 |
| A Study of YP05002 in Healthy Participants (NCT07089823) | Yaopharma Co., Ltd. | 2025-08-19 |
| DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) (NCT07059650) | Dizal Pharmaceuticals | 2025-08-19 |
| A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy Participants (NCT07102316) | Insmed Incorporated | 2025-08-19 |
| Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer (NCT07115446) | Hansoh BioMedical R&D Company | 2025-08-19 |
| A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis (NCT06989645) | Synartro AB | 2025-08-19 |
| [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers (NCT06479811) | National Cancer Institute (NCI) | 2025-08-19 |